Inari Medical, Inc.
NARI · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $3,686 | $3,358 | $4,547 | $2,796 |
| - Cash | $39 | $60 | $93 | $114 |
| + Debt | $32 | $32 | $29 | $0 |
| Enterprise Value | $3,679 | $3,330 | $4,483 | $2,682 |
| Revenue | $494 | $383 | $277 | $140 |
| % Growth | 28.7% | 38.4% | 98.3% | – |
| Gross Profit | $435 | $339 | $252 | $127 |
| % Margin | 88% | 88.4% | 91.1% | 90.6% |
| EBITDA | $15 | -$18 | $16 | $16 |
| % Margin | 3.1% | -4.8% | 5.6% | 11.7% |
| Net Income | -$2 | -$29 | $10 | $14 |
| % Margin | -0.3% | -7.6% | 3.6% | 9.9% |
| EPS Diluted | -0.029 | -0.55 | 0.18 | 0.27 |
| % Growth | 94.8% | -405.6% | -33.3% | – |
| Operating Cash Flow | $36 | -$14 | $25 | $2 |
| Capital Expenditures | -$6 | -$10 | -$14 | -$5 |
| Free Cash Flow | $30 | -$24 | $12 | -$4 |